ARCHIVES

FDA Expands Nexavar Indication To Include Thyroid Cancer

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Possible Breach of Patient Confidentially By Calif. Physician; NCI

May 6, 1994

ASCO Annual Report Names Significant Clinical Research Advances Of Past Year

December 25, 2009

Three Win Nobel Prize In Medicine; Irving Center Awarded $10M For Breast Cancer Research.

October 13, 2000

LDK378 Demonstrates 58 Percent Overall Response Rate in Phase I

April 25, 2014

UCLA Hutchinson, UPa. Reportedly Winners Of Fast Neutron Awards

September 21, 1979

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011